Michael E. Beil

736 total citations
28 papers, 447 citations indexed

About

Michael E. Beil is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Michael E. Beil has authored 28 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Michael E. Beil's work include Nitric Oxide and Endothelin Effects (9 papers), Renin-Angiotensin System Studies (5 papers) and Hormonal Regulation and Hypertension (5 papers). Michael E. Beil is often cited by papers focused on Nitric Oxide and Endothelin Effects (9 papers), Renin-Angiotensin System Studies (5 papers) and Hormonal Regulation and Hypertension (5 papers). Michael E. Beil collaborates with scholars based in Switzerland, United States and Netherlands. Michael E. Beil's co-authors include Arco Y. Jeng, Dean F. Rigel, Fumin Fu, N Levens, Angelo J. Trapani, James L. Bergey, Charles W. Bruseo, Guiqing Liang, Paula Savage and Stéphane De Lombaert and has published in prestigious journals such as The FASEB Journal, Journal of Applied Physiology and Journal of Medicinal Chemistry.

In The Last Decade

Michael E. Beil

28 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Beil Switzerland 12 149 144 125 95 62 28 447
Kozo Yao Japan 14 82 0.6× 172 1.2× 172 1.4× 127 1.3× 52 0.8× 27 598
Wieslawa Maniara Switzerland 9 176 1.2× 235 1.6× 142 1.1× 58 0.6× 30 0.5× 15 532
Soliman A. Bakr Saudi Arabia 11 117 0.8× 119 0.8× 226 1.8× 78 0.8× 40 0.6× 22 773
N Kaul Canada 9 77 0.5× 323 2.2× 219 1.8× 121 1.3× 41 0.7× 14 746
Agnieszka Kij Poland 16 64 0.4× 81 0.6× 237 1.9× 101 1.1× 60 1.0× 40 670
Subbarao Vemulapalli United States 17 114 0.8× 283 2.0× 219 1.8× 211 2.2× 45 0.7× 37 725
Alice Pignieri Italy 11 72 0.5× 150 1.0× 138 1.1× 71 0.7× 67 1.1× 14 463
Marc‐André Laplante Canada 10 89 0.6× 189 1.3× 137 1.1× 177 1.9× 44 0.7× 14 507
Hiroyasu Hirose Japan 10 91 0.6× 52 0.4× 132 1.1× 136 1.4× 106 1.7× 16 505
Beth Musser United States 9 53 0.4× 127 0.9× 152 1.2× 40 0.4× 235 3.8× 11 531

Countries citing papers authored by Michael E. Beil

Since Specialization
Citations

This map shows the geographic impact of Michael E. Beil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Beil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Beil more than expected).

Fields of papers citing papers by Michael E. Beil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Beil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Beil. The network helps show where Michael E. Beil may publish in the future.

Co-authorship network of co-authors of Michael E. Beil

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Beil. A scholar is included among the top collaborators of Michael E. Beil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Beil. Michael E. Beil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ploeger, Bart A., Olivier Luttringer, Dean F. Rigel, et al.. (2016). Characterization and Prediction of Cardiovascular Effects of Fingolimod and Siponimod Using a Systems Pharmacology Modeling Approach. Journal of Pharmacology and Experimental Therapeutics. 360(2). 356–367. 7 indexed citations
2.
Papillon, Julien P. N., Alok Kumar Singh, Christopher M. Adams, et al.. (2015). Discovery of N-[5-(6-Chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-ethanesulfonamide, a Cortisol-Sparing CYP11B2 Inhibitor that Lowers Aldosterone in Human Subjects. Journal of Medicinal Chemistry. 58(23). 9382–9394. 23 indexed citations
3.
Ménard, Joël, Dean F. Rigel, Catherine E. Watson, et al.. (2014). Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects. Journal of Translational Medicine. 12(1). 340–340. 47 indexed citations
4.
Ploeger, Bart A., Olivier Luttringer, Dean F. Rigel, et al.. (2013). PKPDmodelling of the interrelationship between mean arterialBP, cardiac output and total peripheral resistance in conscious rats. British Journal of Pharmacology. 169(7). 1510–1524. 23 indexed citations
5.
6.
Korach-André, Marion, John Gounarides, Richard Deacon, et al.. (2005). Age and muscle-type modulated role of intramyocellular lipids in the progression of insulin resistance in nondiabetic Zucker rats. Metabolism. 54(4). 522–528. 18 indexed citations
7.
Trapani, Angelo J., et al.. (2004). CGS 35601 and its Orally Active Prodrug CGS 37808 as Triple Inhibitors of Endothelin-converting Enzyme-1, Neutral Endopeptidase 24.11, and Angiotensin-converting Enzyme. Journal of Cardiovascular Pharmacology. 44(Supplement 1). S211–S215. 10 indexed citations
8.
Gude, Candido, Kenneth Chan, Jenny Tan, et al.. (2002). Synthesis and biological activity of potent heterocyclic thiol-based inhibitors of endothelin-converting enzyme-1. Bioorganic & Medicinal Chemistry Letters. 12(21). 3059–3062. 9 indexed citations
9.
Savage, Paula, Michael E. Beil, Charles W. Bruseo, et al.. (2002). CGS 34226, a thiol-based dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11. Clinical Science. 103(s2002). 98S–101S. 11 indexed citations
10.
Gude, Candido, Kenneth Chan, Cynthia A. Fink, et al.. (2001). Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(3). 375–378. 9 indexed citations
11.
Trapani, Angelo J., Stéphane De Lombaert, Michael E. Beil, et al.. (2000). Cgs 34043. Life Sciences. 67(9). 1025–1033. 10 indexed citations
12.
Jeng, Arco Y., Stéphane De Lombaert, Michael E. Beil, et al.. (2000). Design and Synthesis of a Potent and Selective Endothelin-Converting Enzyme Inhibitor, CGS 35066. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S36–S39. 19 indexed citations
13.
Trapani, Angelo J., Michael E. Beil, Charles W. Bruseo, Stéphane De Lombaert, & Arco Y. Jeng. (2000). Pharmacological Properties of CGS 35066, a Potent and Selective Endothelin-Converting Enzyme Inhibitor, in Conscious Rats. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S40–S43. 17 indexed citations
14.
Fink, Cynthia A., Daniël Hoyer, Ying Qiao, et al.. (2000). Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1. Bioorganic & Medicinal Chemistry Letters. 10(17). 2037–2039. 11 indexed citations
15.
16.
Stephan, Z.F., et al.. (1994). Marked reduction of LDL and Lp(a) by CGS 26214, a selective cardiac-sparing thyromimetic in cynomolgus monkeys. Atherosclerosis. 109(1-2). 323–323. 1 indexed citations
17.
Levens, N, Michael E. Beil, & Richard Schulz. (1991). Intrarenal actions of the new adenosine agonist CGS 21680A, selective for the A2 receptor.. Journal of Pharmacology and Experimental Therapeutics. 257(3). 1013–1019. 8 indexed citations
18.
Levens, N, et al.. (1991). Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.. Journal of Pharmacology and Experimental Therapeutics. 257(3). 1005–1012. 40 indexed citations
19.
Beil, Michael E., et al.. (1987). Effects of Metoprolol, Alone and in Combination with Lidocaine, on Ventricular Fibrillation Threshold. Journal of Cardiovascular Pharmacology. 9(5). 611–621. 7 indexed citations
20.
Bergey, James L. & Michael E. Beil. (1983). Antiarrhythmic evaluation of naloxone against acute coronary occlusion-induced arrhythmias in pigs. European Journal of Pharmacology. 90(4). 427–431. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kozo Yao Breakdown of academic impact, for papers by Wieslawa Maniara Breakdown of academic impact, for papers by Soliman A. Bakr Breakdown of academic impact, for papers by N Kaul Breakdown of academic impact, for papers by Agnieszka Kij Breakdown of academic impact, for papers by Subbarao Vemulapalli Breakdown of academic impact, for papers by Alice Pignieri Breakdown of academic impact, for papers by Marc‐André Laplante Breakdown of academic impact, for papers by Hiroyasu Hirose Breakdown of academic impact, for papers by Beth Musser
Rankless by CCL
2026